Neuroimmune pathophysiology of long COVID
Psychiatry and Clinical Neurosciences · 2025
DOI: 10.1111/pcn.13855 ↗At a glance
Übersichtsarbeit in Psychiatry and Clinical Neurosciences, 2025. Written by Janna K Moen and 2 co-authors. Institution: Howard Hughes Medical Institute, Chevy Chase, Maryland, USA. Major MEDLINE topics: COVID-19, Neuroimmunomodulation, Nervous System Diseases, Peripheral Nervous System Diseases. Cited 39 times so far (Crossref); 342 references. The full text is freely available (open access, CC BY 4.0). Funded by: Howard Hughes Medical Institute, NIAID NIH HHS, National Institute of Allergy and Infectious Diseases.
Abstract (original language)
Although COVID‐19 was originally considered a respiratory illness, it is now well established that SARS‐CoV‐2 infection can have far‐reaching impacts on the nervous system. Neurological symptoms such as chemosensory dysfunction are frequently observed during acute infection and approximately 10% of COVID‐19 cases will go on to develop new or persistent long‐term symptoms, a condition known in the literature as post‐acute symptoms of COVID‐19 (PASC) or by the patient‐coined term Long COVID. Common neurological symptoms in Long COVID include new onset cognitive difficulties, dysautonomia, fatigue, and peripheral neuropathy. The emergence of Long COVID has prompted renewed interest in the study of post‐acute infection syndromes (PAIS), particularly in the area of neuroimmune interactions. In this review we provide a comprehensive overview of the current body of literature on neurological manifestations of SARS‐CoV‐2 infection and Long COVID, with an emphasis on neuroimmune mechanisms drawn largely from autopsy studies and animal models. A more complete understanding of neuroimmune crosstalk in Long COVID will not only guide the development of therapies for this highly disabling condition but will also contribute to our general understanding of neuroimmune interactions in health and disease.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Howard Hughes Medical Institute, Chevy Chase, Maryland, USA.
- Department of Immunobiology, Yale University School of Medicine, New Haven, Connecticut, USA.
- Center for Infection and Immunity, Yale University School of Medicine, New Haven, Connecticut, USA.
ORCID profiles: Janna K Moen, Christopher A Baker, Akiko Iwasaki
Funding
- Howard Hughes Medical Institute
- NIAID NIH HHS
- National Institute of Allergy and Infectious Diseases
Cite
APA
Moen, J. K., Baker, C. A., & Iwasaki, A. (2025). Neuroimmune pathophysiology of long COVID. Psychiatry and Clinical Neurosciences. https://doi.org/10.1111/pcn.13855
Vancouver
Moen JK, Baker CA, Iwasaki A. Neuroimmune pathophysiology of long COVID. Psychiatry and Clinical Neurosciences. 2025. doi:10.1111/pcn.13855
BibTeX
@article{Moen2025,
author = {Moen, Janna K and Baker, Christopher A and Iwasaki, Akiko},
title = {Neuroimmune pathophysiology of long COVID},
journal = {Psychiatry and Clinical Neurosciences},
year = {2025},
doi = {10.1111/pcn.13855}
}
EUVIMED